Yidu Tech Inc.

Research Yidu Tech Inc. (2158.HK) on Bullrun: market cap HKD 2.93B, P/E 35.9, dividend yield 1.4%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is HKD 2.93B; P/E is 35.9; dividend yield is 1.4%.

Peer valuation comparison

Latest P/E is 35.88x versus a Healthcare sector median of 21.69x (65.4% above).

Latest dividend yield is 1.43% versus a Healthcare sector median of 2.41% (40.7% below).

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2026CNY 819.30MCNY 72.71M-CNY 51.63M36.4%0.07CNY 664.76MCNY 71.09MCNY 3.65B
FY2025CNY 714.98M-CNY 117.79M-CNY 350.78M33.5%-0.11CNY 1.32BCNY 129.54MCNY 3.92B
FY2024CNY 807.08M-CNY 194.94M-CNY 367.20M42.1%-0.19CNY 1.41BCNY 95.20MCNY 4.02B
FY2023CNY 804.70M-CNY 627.97M-CNY 378.19M34.1%-0.63CNY 1.17BCNY 14.13MCNY 4.08B

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18HKD 2.93B35.91.4%0.04

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0.04 HKD, yield 1.4%.

YearDividends/share
FY20260.04 CNY

About Yidu Tech Inc.

Yidu Tech Inc., an investment holding company, provides healthcare solutions built on big data and artificial intelligence (AI) technologies in the People's Republic of China, Brunei, Singapore, and internationally. The company operates through AI for Medical, AI for Life Sciences, and AI for Care segments.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Yidu Tech Inc.'s market cap?

Yidu Tech Inc.'s market capitalization is HKD 2.93B.

What is Yidu Tech Inc.'s P/E ratio?

Yidu Tech Inc.'s price-to-earnings (P/E) ratio is 35.9.

Does Yidu Tech Inc. pay a dividend?

Yidu Tech Inc. has a dividend yield of 1.4%.

What does Yidu Tech Inc. do?

Yidu Tech Inc., an investment holding company, provides healthcare solutions built on big data and artificial intelligence (AI) technologies in the People's Republic of China, Brunei, Singapore, and internationally. The company operates through AI for Medical, AI for Life Sciences, and AI for Care segments.